Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2026-05-21 @ 12:17 PM
Study NCT ID:
NCT05034133
Status:
UNKNOWN
Last Update Posted:
2021-09-05
First Post:
2021-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
Sponsor:
Beijing Haidian Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BHHMEC-XM-2021-43
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None